SCHEMBL1477095

SCHEMBL1477095

CC(Oc1ccccc1F)C1CCNCC1

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 11/20 0.59
SLC6A3 Q01959 9/20 0.59
SLC6A4 P31645 8/20 0.59
HTR1A P08908 7/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL934190 0.81 SLC6A2 (0.64) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL934191 0.81 SLC6A2 (0.64) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL934920 0.81 SLC6A2 (0.64) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL3895159 0.80 SLC6A2 (0.84) SLC6A2SLC6A3SLC6A4
SCHEMBL21984762 0.80 SLC6A2 (0.49) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL21984953 0.79 SLC6A4 (0.62) SLC6A2SLC6A3SLC6A4
SCHEMBL21985301 0.79 DPP4 (0.45) SLC6A2SLC6A3SLC6A4
SCHEMBL21985033 0.78 SLC6A2 (0.44) SLC6A2SLC6A3SLC6A4
SCHEMBL954261 0.78 SLC6A2 (0.60) SLC6A2SLC6A3SLC6A4HTR1A
SCHEMBL934163 0.78 SLC6A2 (0.60) SLC6A2SLC6A3SLC6A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
CN-100389113-C Nitrogen-containing heterocyclic compound and drug containing same EISAI CO LTD (JP) 2008-05-21 CN disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-7265108-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2007-09-04 US disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
US-6995144-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2006-02-07 US disclosed
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
CN-1630650-A Nitrogen-containing heterocyclic compound and drug containing same EISAI CO LTD (JP) 2005-06-22 CN disclosed
EP-1484327-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF Eisai Co., Ltd. (JP) 2004-12-08 EP disclosed
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 SLC6A2 1216/4885SLC6A3 1349/4885SLC6A4 826/4885
US-20040167224-A1 Nitrogen containing heterocyclic compounds and medicines containing the same NQO1, CBR1, NOX1 SLC6A2 1196/4885SLC6A3 1258/4885SLC6A4 789/4885
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 SLC6A2 1216/4885SLC6A3 1349/4885SLC6A4 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.